Literature DB >> 7489321

Inhibition of nitric oxide synthase in the hypothalamus blocks the increase in plasma prolactin induced by intraventricular injection of interleukin-1 alpha in the rat.

V Rettori1, N Belova, M Gimeno, S M McCann.   

Abstract

Injection of interleukin-1 (IL-1) into the third cerebral ventricle (3V) of conscious rats increases plasma prolactin (PRL) concentration. Nitric oxide (NO) is involved in control of corticotropin-releasing factor (CRF) and luteinizing hormone-releasing hormone (LHRH) release. Consequently, we evaluated its role in the PRL-releasing action of IL-1. In the present experiment, NG-mono-methyl-L-arginine (NMMA) (1 mg in 5 microliters of 0.9% NaCl (saline)], an inhibitor of NO synthase, or 5 microliter of saline was microinjected into the 3V of conscious, castrate male rats and blood samples were removed from jugular catheters just prior to and at 10-min intervals after injection. A second injection of NMMA or saline was given 60 min after the first. Five minutes after the injection of NMMA or saline, IL-1 alpha (0.6 pmol in 2 microliter saline), or an equal volume of saline, was injected into the 3V. Plasma PRL concentrations were increased within 10-20 min after injection of IL-1 alpha and a second pulse of PRL usually occurred at 60-70 min following its injection. The maximal increase in plasma PRL from the initial value in the animals injected with IL-1 alpha was highly significant, whereas there was no significant increase in the animals injected with NMMA plus IL-1 alpha or in the animals injected with saline or NMMA. The area under the plasma PRL curve was significantly elevated in the animals injected with IL-1 alpha above that of rats injected with NMMA plus IL-1 alpha during the first hour after injection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7489321     DOI: 10.1159/000097144

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  6 in total

1.  In vitro, nitric oxide (NO) stimulates LH secretion and partially prevents the inhibitory effect of dopamine on PRL release.

Authors:  D González; E Aguilar
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

2.  Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man.

Authors:  M Maccario; S E Oleandri; M Procopio; S Grottoli; E Avogadri; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

3.  Nitric oxide inhibits hypothalamic luteinizing hormone-releasing hormone release by releasing gamma-aminobutyric acid.

Authors:  A Seilicovich; B H Duvilanski; D Pisera; S Theas; M Gimeno; V Rettori; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

4.  Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus.

Authors:  Shenglong Zou; Rishi K Somvanshi; Seungil Paik; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2014-07-08       Impact factor: 3.444

5.  A neuromodulatory role of interleukin-1beta in the hippocampus.

Authors:  H Schneider; F Pitossi; D Balschun; A Wagner; A del Rey; H O Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

6.  Loss of the centrosomal protein Cenpj leads to dysfunction of the hypothalamus and obesity in mice.

Authors:  Wenyu Ding; Changjiang Zhang; Baisong Wang; Xin Zhou; Le Sun; Suijuan Zhong; Jing Liu; Junjing Zhang; Xiaoqun Wang; Qian Wu
Journal:  Sci China Life Sci       Date:  2020-08-13       Impact factor: 6.038

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.